Page 389 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 389

CHAPTER 21  Introduction to the Pharmacology of CNS Drugs         375


                    CENTRAL NEUROTRANSMITTERS                            present on inhibitory interneurons, lack the GluA2 subunit and
                                                                                            2+
                                                                         are also permeable to Ca .
                    Because drug selectivity is based on the fact that different path-  Kainate receptors are not as uniformly distributed as AMPA
                    ways use different transmitters, a primary goal of neuroscience   receptors,  being  expressed  at  high  levels  in  the  hippocampus,
                    has been to identify the neurotransmitters in CNS pathways.   cerebellum, and spinal cord. They are formed from a number of
                    Establishing that a chemical substance is a transmitter has been   subunit combinations (GluK1–GluK5). Although GluK4 and
                    far more difficult for central synapses than for peripheral syn-  GluK5 are unable to form channels on their own, their presence
                    apses.  The following criteria were established for transmitter   in the receptor changes the receptor’s affinity and kinetics. Similar
                                                                                                                      +
                    identification.                                      to AMPA receptors, kainate receptors are permeable to Na  and
                                                                          +
                                                                         K  and in some subunit combinations can also be permeable to
                    1. Localization: A suspected transmitter must reside in the presyn-  Ca . Domoic acid, a toxin produced by algae and concentrated
                                                                           2+
                      aptic terminal of the pathway of interest.         in shellfish, is a potent agonist at kainate and AMPA receptors.
                    2. Release: A suspected transmitter must be released from a neu-  Consumption of contaminated shellfish has been implicated in
                      ron in response to neuronal activity and in a calcium-depen-  illness in animals and humans.
                      dent manner.                                         NMDA receptors are as ubiquitous as AMPA receptors, being
                    3. Synaptic Mimicry: Application of the candidate substance   present on essentially all neurons in the CNS. All NMDA recep-
                      should produce a response that mimics the action of the trans-  tors require the presence of the subunit GluN1. The channel also
                      mitter released by nerve stimulation, and application of a selec-  contains one or two GluN2 subunits (GluN2A–GluN2D). Unlike
                      tive antagonist should block the response.         AMPA and kainate receptors, all NMDA receptors are highly
                                                                                                        +
                                                                                     2+
                                                                                                  +
                       Using the criteria above, a vast number of small molecules have   permeable to Ca  as well as to Na  and K . NMDA receptor func-
                    been isolated from the brain, and studies using a variety of approaches   tion is controlled in a number of intriguing ways. In addition to
                    suggest that the agents listed in Table 21–2 are neurotransmitters. A   glutamate binding, the channel also requires the binding of glycine
                    brief summary of some of these compounds follows.    to a separate site in order for the channel to open. However, the
                                                                         regulation and physiologic role of glycine binding remain unclear.
                    Amino Acid Neurotransmitters                         Another important feature is that while AMPA and kainate recep-
                                                                         tor activation results in channel opening at resting membrane
                    The amino acids of primary interest to the pharmacologist fall   potential, NMDA receptor activation does not. This is because, at
                    into two categories: the acidic amino acid glutamate and the neu-  resting membrane potential, the NMDA receptor pore is blocked
                    tral amino acids glycine and GABA. These compounds are pres-  by extracellular Mg . Only when the neuron is strongly depolar-
                                                                                        2+
                    ent in high concentrations in the CNS and are extremely potent   ized, as occurs with intense activation of the synapse or by activa-
                    modifiers of neuronal excitability.                  tion of neighboring synapses, is the Mg  expelled, allowing the
                                                                                                        2+
                                                                         channel to open. Thus, there are three requirements for NMDA
                    A.  Glutamate                                        receptor channel opening: Glutamate and glycine must bind the
                    Excitatory synaptic transmission is mediated by glutamate, which   receptor, and the membrane must be depolarized. The rise in intra-
                                                                                 2+
                    is present in very high concentrations in excitatory synaptic   cellular Ca  that accompanies NMDA receptor channel opening
                    vesicles (~100 mM). Glutamate is released into the synaptic   results in a long-lasting enhancement in synaptic strength that is
                             2+
                    cleft by Ca -dependent exocytosis. The released glutamate acts   referred to as long-term potentiation (LTP). This enhancement
                    on postsynaptic glutamate receptors and is cleared by glutamate   of synaptic strength, which is one major type of synaptic plasticity,
                    transporters present on surrounding glia (Figure 21–7). In glia,   can last for many hours or even days and is generally accepted as an
                    glutamate is converted to glutamine by glutamine synthetase,   important cellular mechanism underlying learning and memory.
                    released from the glia, taken up by the nerve terminal, and con-  The metabotropic glutamate receptors are G protein-coupled
                    verted back to glutamate by the enzyme glutaminase. The high   receptors that act indirectly on ion channels via G proteins.
                    concentration of glutamate in synaptic vesicles is achieved by the   Metabotropic receptors (mGluR1–mGluR8) have been divided
                    vesicular glutamate transporter (VGLUT).             into three groups (I, II, and III). A variety of agonists and
                       Almost all neurons that have been tested are strongly excited   antagonists have been developed that interact selectively with the
                    by glutamate. This excitation is caused by the activation of both   different groups. Group I receptors are typically located postsyn-
                    ionotropic and metabotropic receptors, which have been exten-  aptically and activate phospholipase C, leading to inositol tri-
                                                                                                     2+
                    sively characterized by molecular cloning. The ionotropic recep-  sphosphate-mediated intracellular Ca  release. In contrast, group
                    tors are divided into three subtypes based on the action of selective   II and  group III  receptors  are typically located on presynaptic
                    agonists: α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid   nerve terminals and act as inhibitory autoreceptors. Activation of
                                                                                                         2+
                    (AMPA), kainic acid (KA), and N-methyl-d-aspartate (NMDA).   these receptors causes the inhibition of Ca  channels, resulting in
                    All the ionotropic receptors are composed of four subunits. AMPA   inhibition of transmitter release. These receptors are activated only
                    receptors, which are present on all neurons, are heterotetramers   when the concentration of glutamate rises to high levels during
                    assembled from four subunits (GluA1–GluA4). The majority of   repetitive stimulation of the synapse. Activation of these receptors
                    AMPA receptors contain the GluA2 subunit and are permeable   also causes the inhibition of adenylyl cyclase and decreases cAMP
                              +
                                           2+
                         +
                    to Na  and K , but not to Ca . Some AMPA receptors, typically   generation.
   384   385   386   387   388   389   390   391   392   393   394